The Journal of Pain
Volume 11, Issue 6 , Pages 535-544 , June 2010

Thermal Nociception is Decreased by Hypocretin-1 and an Adenosine A1 Receptor Agonist Microinjected into the Pontine Reticular Formation of Sprague Dawley Rat

Received 31 March 2009 ,Revised 31 August 2009 ,Accepted 18 September 2009.

References 

  1. Baghdoyan HA. Hyperalgesia induced by REM sleep loss: A phenomenon in search of a mechanism. Sleep. 2006;29:137–139
  2. Bartsch T, Levy MJ, Knight YE, Goadsby PJ. Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area. Pain. 2004;109:367–378
  3. Bernard R, Lydic R, Baghdoyan HA. Hypocretin (orexin) receptor subtypes differentially enhance acetylcholine release and activate G protein subtypes in rat pontine reticular formation. J Pharmacol Exp Ther. 2006;317:163–171
  4. Bian D, Nichols ML, Ossipov MH, Lai J, Porreca F. Characterization of the antiallodynic efficacy of morphine in a model of neuropathic pain in rats. Neuroreport. 1995;6:1981–1984
  5. Bingham S, Davey PT, Babbs AJ, Irving EA, Sammons MJ, Wyles M, et al. Orexin-A, an hypothalamic peptide with analgesic properties. Pain. 2001;92:81–90
  6. Brummett CM, Norat MA, Palmisano JM, Lydic R. Perineural administration of dexmedetomidine in combination with bupivacaine enhances sensory and motor blockade in sciatic nerve block without inducing neurotoxicity in rat. Anesthesiology. 2008;109:502–511
  7. Cheng J-K, Chou RC-C, Hwang L-L, Chiou L-C. Antiallodynic effects of intrathecal orexins in a rat model of postoperative pain. J Pharmacol Exp Ther. 2003;307:1065–1071
  8. Coleman CG, Baghdoyan HA, Lydic R. Dialysis delivery of an adenosine A2A agonist into the pontine reticular formation of C57BL/6J mouse increases pontine acetylcholine release and sleep. J Neurochem. 2006;96:1750–1759
  9. Date Y, Mondal MS, Matsukura S, Nakazato M. Distribution of orexin-A and orexin-B (hypocretins) in the rat spinal cord. Neurosci Lett. 2000;288:87–90
  10. Dunwiddie TV, Masino SA. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci. 2001;24:31–55
  11. Eisenach JC, Hood DD, Curry R. Preliminary efficacy assessment of intrathecal injection of an American formulation of adenosine in humans. Anesthesiology. 2002;96:29–34
  12. Erichsen HK, Hao J-X, Xu X-J, Blackburn-Munro G. Comparative actions of the opioid analgesics morphine, methadone and codeine in rat models of peripheral and central neuropathic pain. Pain. 2005;116:347–358
  13. Geisser ME, Wang W, Smuck M, Koch LG, Britton SL, Lydic R. Nociception before and after exercise in rats bred for high and low aerobic capacity. Neurosci Lett. 2008;443:37–40
  14. Haack M, Mullington JM. Sustained sleep restriction reduces emotional and physical well-being. Pain. 2005;119:56–64
  15. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 1988;32:77–88
  16. Hayes RL, Katayama Y, Watkins LR, Becker DP. Bilateral lesions of the dorsolateral funiculus of the cat spinal cord: Effects on basal nociceptive reflexes and nociceptive suppression produced by cholinergic activation of the pontine parabrachial region. Brain Res. 1984;311:267–280
  17. Hervieu GJ, Cluderay JE, Harrison DC, Roberts JC, Leslie RA. Gene expression and protein distribution of the orexin-1 receptor in the rats brain and spinal cord. Neuroscience. 2001;103:777–797
  18. Kelz MB, Sun Y, Chen J, Cheng Meng Q, Moore JT, Veasey SC, et al. An essential role for orexins in emergence from general anesthesia. Proc Natl Acad Sci U S A. 2008;105:1309–1314
  19. Kiyashchenko LI, Mileykovskiy BY, Maidment N, Lam HA, Wu M-F, John J, et al. Release of hypocretin (orexin) during waking and sleep states. J Neurosci. 2002;22:5282–5286
  20. Kshatri AM, Baghdoyan HA, Lydic R. Cholinomimetics, but not morphine, increase antinociceptive behavior from pontine reticular regions regulating rapid-eye-movement sleep. Sleep. 1998;21:677–685
  21. Kushikata T, Hirota K, Yoshida H, Kudo M, Lambert DG, Smart D, et al. Orexinergic neurons and barbiturate anesthesia. Neuroscience. 2003;121:855–863
  22. Lavigne G, Roehrs T. Pain and sleep: A scientific and clinical conference. Washington, DC: National Sleep Foundation; 2009;
  23. Lydic R, Baghdoyan HA. Sleep, anesthesiology, and the neurobiology of arousal state control. Anesthesiology. 2005;103:1268–1295
  24. Lydic R, Baghdoyan HA. Neurochemical mechanisms mediating opioid-induced REM sleep disruption. In:  Lavigne G,  Sessle BJ,  Choinière M,  Soja PJ editor. Sleep and Pain. First Edition. Seattle, WA: IASP Press; 2007;p. 99–122
  25. Marks GA, Birabil CG. Enhancement of rapid eye movement sleep in the rat by cholinergic and adenosinergic agonists infused into the pontine reticular formation. Neuroscience. 1998;86:29–37
  26. Marston OJ, Williams RH, Canal MM, Samuels RE, Upton N, Piggins HD. Circadian and dark-pulse activation of orexin/hypocretin neurons. Molecular Brain. 2008;1:19
  27. Mobarakeh JI, Takahashi K, Sakurada S, Nishino S, Watanabe H, Kato M, et al. Enhanced antinociception by intracerebroventricularly administered orexin A in histamine H1 or H2 receptor gene knockout mice. Pain. 2005;118:254–262
  28. Mogil JS, Chesler EJ, Wilson SG, Juraska JM, Sternberg WF. Sex differences in thermal nociception and morphine antinociception in rodents depend on genotype. Neurosci Behav Rev. 2000;24:375–389
  29. Nishino S, Sakurai T. The Orexin/Hypocretin System: Physiology and Pathophysiology. First Edition. Totowa, NJ: Humana Press, Inc; 2006;
  30. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 4th ed.. New York NY: Academic Press; 1998;
  31. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci. 1998;18:9996–10015
  32. Price DD. Psychological and neural mechanisms of the affective dimension of pain. Science. 2000;288:1769–1772
  33. Roehrs T, Hyde M, Blaisdell B, Greenwald M, Roth T. Sleep loss and REM sleep loss are hyperalgesic. Sleep. 2006;29:145–151
  34. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92:573–585
  35. Smith MT: The role of sleep in hyperalgesia and persistent pain, at the American Pain Society 28th Annual Scientific Meeting, San Diego, CA, 2009
  36. Smith MT, Edwards RR, McCann UD, Haythornthwaite JA. The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep. 2007;30:494–505
  37. Tanase D, Baghdoyan HA, Lydic R. Microinjection of an adenosine A1 agonist into the medial pontine reticular formation increases tail flick latency to thermal stimulation. Anesthesiology. 2002;97:1597–1601
  38. Tanase D, Baghdoyan HA, Lydic R. Dialysis delivery of an adenosine A1 receptor agonist to the pontine reticular formation decreases acetylcholine release and increases anesthesia recovery time. Anesthesiology. 2003;98:912–920
  39. Tanase D, Martin WA, Baghdoyan HA, Lydic R. G protein activation in rat ponto-mesencephalic nuclei is enhancd by combined treatment with a mu opioid and an adenosine A1 receptor agonist. Sleep. 2001;24:1–11
  40. Van den Pol AN. Hypothalamic hypocretin (orexin): Robust innervation of the spinal cord. J Neurosci. 1999;19:3171–3182
  41. Wang W, Baghdoyan HA, Lydic R. Leptin replacement restores supraspinal cholinergic antinociception in leptin deficient obese mice. J Pain. 2009;10:836–843
  42. Watson CJ, Soto-Calderon H, Lydic R, Baghdoyan HA. Pontine reticular formation (PnO) administration of hypocretin-1 increases PnO GABA levels and wakefulness. Sleep. 2008;31:453–464
  43. Watson SL, Battersby AS, Watson CJ, Baghdoyan HA, Lydic R: Increase in antinociception caused by microinjection of hypocretin-1 (hcrt-1) into the pontine reticular nucleus, oral part (PnO) of Sprague Dawley rat is blocked by the hcrt receptor-1 (hcrt-r1) antagonist SB-334867. Program No. 270.18. 2008 Neuroscience Meeting Planner. Washington, DC: Society of Neuroscience, 2008. Available at: http://www.abstractsonline.com Accessed August 25, 2009
  44. Watson SL, Watson CJ, Baghdoyan HA, Lydic R: Response to nociceptive input is decreased by the adenosine A1 receptor agonist N6-p-sulfophenyladenosine (SPA), but not by hypocretin-1 (hcrt), microinjected into the pontine reticular formation (PRF) of Sprague-Dawley rat. Program No. 248.5. 2006 Neuroscience Meeting Planner. Atlanta, GA: Society for Neuroscience, 2006. Available at: http://www.abstractsonline.com Accessed August 25, 2009
  45. Watson SL, Watson CJ, Baghdoyan HA, Lydic R. Microinjection of hypocretin-1 into the pontine reticular nucleus, oral part (PnO) of Sprague-Dawley rat decreases response to nociceptive input. J Pain. 2008;9(Suppl 2):P7
  46. Yamamoto T, Saito O, Shono K, Aoe T, Chiba T. Anti-mechanical allodynic effect of intrathecal and intracerebroventricular injection of orexin-A in the rat neuropathic pain model. Neurosci Lett. 2003;347:183–186
  47. Yamamoto T, Saito O, Shono K, Hirasawa S. Activation of spinal orexin-1 receptor produces anti-allodynic effect in the rat carrageenan test. Eur J Pharmacol. 2003;481:175–180

 Supported by National Institutes of Health grants HL57120, HL40881, MH45361, and the Department of Anesthesiology.

PII: S1526-5900(09)00765-2

doi: 10.1016/j.jpain.2009.09.010

The Journal of Pain
Volume 11, Issue 6 , Pages 535-544 , June 2010

Article Tools

* Image Usage & Resolution